VIVO CAPITAL

vivo-capital-logo

The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

#People #Financial #Event #More

VIVO CAPITAL

Social Links:

Industry:
Finance Financial Services Health Care Venture Capital

Founded:
1996-01-01

Status:
Active

Contact:
(650) 688-0818

Email Addresses:
[email protected]

Technology used in webpage:
SPF DNS Made Easy DNS DNS Made Easy Tiggee


Current Employees Featured

shan-fu_image

Shan Fu
Shan Fu Managing Partner @ Vivo Capital
Managing Partner

edgar-g-engleman_image

Edgar G. Engleman
Edgar G. Engleman Co - Founder & Managing Partner @ Vivo Capital
Co - Founder & Managing Partner

frank-kung_image

Frank Kung
Frank Kung Managing Partner @ Vivo Capital
Managing Partner

joseph-siletto_image

Joseph Siletto
Joseph Siletto Managing Director @ Vivo Capital
Managing Director

tiantian-zhu_image

Tiantian Zhu
Tiantian Zhu Associate @ Vivo Capital
Associate

michael-chang_image

Michael Chang
Michael Chang Managing Partner @ Vivo Capital
Managing Partner
2012-01-01

mitchell-mutz_image

Mitchell Mutz
Mitchell Mutz Entrepreneur Partner @ Vivo Capital
Entrepreneur Partner
2021-07-01

chloe-zhang_image

Chloe Zhang
Chloe Zhang Principal @ Vivo Capital
Principal

sue-shao_image

Sue Shao
Sue Shao Principal @ Vivo Capital
Principal

jack-nielsen_image

Jack Nielsen
Jack Nielsen Managing Partner @ Vivo Capital
Managing Partner
2017-08-01

Founder


edgar-g-engleman_image

Edgar G. Engleman

frank-kung_image

Frank Kung

Acquisitions List

Date Company Article Price
2021-01-08 Serรกn Bioscience Serรกn Bioscience acquired by Vivo Capital N/A
2016-12-19 Angiotech Pharmaceuticals Angiotech Pharmaceuticals acquired by Vivo Capital N/A

Investments List

Date Company Article Money raised
2022-08-11 Klavi Vivo Capital investment in Series A - Klavi 15 M USD
2022-07-11 Inspirna Vivo Capital investment in Series D - Inspirna 55.1 M USD
2022-07-06 Tebra Vivo Capital investment in Series B - Tebra 72 M USD
2022-06-28 Cerebral Therapeutics Vivo Capital investment in Series C - Cerebral Therapeutics 40 M USD
2022-06-09 DBV Technologies Vivo Capital investment in Post-IPO Equity - DBV Technologies 181 M EUR
2022-04-25 Visirna Therapeutics Vivo Capital investment in Seed Round - Visirna Therapeutics 60 M USD
2022-03-23 Ocelot Bio Vivo Capital investment in Series A - Ocelot Bio 36 M USD
2021-12-08 Avistone Pharmaceuticals Vivo Capital investment in Private Equity Round - Avistone Pharmaceuticals 200 M USD
2021-11-29 Ablaze Pharmaceuticals Vivo Capital investment in Series A - Ablaze Pharmaceuticals 75 M USD
2021-10-19 HistoWiz Vivo Capital investment in Series A - HistoWiz 32.25 M USD

Newest Events participated

super-return-asia_event_image Participated in Super Return Asia on 2022-09-19 as sponsor

More informations about "Vivo Capital" on Search Engine